Status:
COMPLETED
The Effect of Body Mass Index on Etonogestrel Hormone Levels in Women Using the Single-rod Contraceptive Implant
Lead Sponsor:
Columbia University
Conditions:
Contraception
Obesity
Eligibility:
FEMALE
Brief Summary
Two-thirds of young women in the United States are overweight or obese. This excess weight may affect how their body metabolizes drugs such as different birth control methods. There is a not a lot of ...
Detailed Description
Two-thirds of reproductive-age women in the United States are either overweight or obese. Body composition may affect contraceptive hormone metabolism and possibly efficacy. Phase III studies to date ...
Eligibility Criteria
Inclusion
- Woman using contraceptive implant for more than 12 months
- English or Spanish-speaking
Exclusion
- None
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT01855620
Start Date
December 1 2012
End Date
March 1 2014
Last Update
April 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032